Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;25(9):1690-8.
doi: 10.3109/14767058.2012.657279. Epub 2012 Apr 25.

The clinical significance of a positive Amnisure test in women with preterm labor and intact membranes

Seung Mi Lee  1 , Roberto Romero, Jeong Woo Park, Sun Min Kim, Chan-Wook Park, Steven J Korzeniewski, Tinnakorn Chaiworapongsa, Bo Hyun Yoon
Affiliations

The clinical significance of a positive Amnisure test in women with preterm labor and intact membranes

Seung Mi Lee et al. J Matern Fetal Neonatal Med. 2012 Sep.

Abstract

Objective: This study was conducted to examine the frequency and clinical significance of a positive Amnisure test in patients with preterm labor and intact membranes by sterile speculum exam.

Study design: A retrospective cohort study was performed including 90 patients with preterm labor and intact membranes who underwent Amnisure tests prior to amniocentesis (< 72 h); most patients (n=64) also underwent fetal fibronectin (fFN) tests. Amniotic fluid (AF) was cultured for aerobic/anaerobic bacteria and genital mycoplasmas and assayed for matrix metalloproteinase-8.

Results: (1) the prevalence of a positive Amnisure test was 19% (17/90); (2) patients with a positive Amnisure test had significantly higher rates of adverse pregnancy and neonatal outcomes (e.g., impending preterm delivery, intra-amniotic infection/inflammation, and neonatal morbidity) than those with a negative Amnisure test; (3) a positive test was associated with significantly increased risk of intra-amniotic infection and/or inflammation, delivery within 7, 14, or 28 days and spontaneous preterm birth (< 35 weeks) among patients with a negative fFN test.

Conclusions: A positive Amnisure test in patients with preterm labor and intact membranes is a risk factor for adverse pregnancy outcome, particularly in patients with a negative fFN test. A positive Amnisure test in patients without symptoms or signs of ROM should not be taken as an indicator that membranes have ruptured.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Amniotic fluid MMP-8 concentrations according to the presence or absence of clinical evidence of ROM and the result of Amnisure test (a negative Amnisure test: median, 1.2 ng/mL [range, 0.3–2109.1 ng/mL]; a positive Amnisure test: median, 49.3 ng/mL [range, 0.3–5304.8 ng/mL])
Figure 2
Figure 2
Kaplan-Meier Survival Distribution Function by Test Result [The median test-to-delivery duration and hazard ratio (95% confidence interval) for each group adjusted for gestational age at test, cervical dilatation, and intra-amniotic infection and/or inflammation are as follows: Amnisure (+) fFN (+): 9.7 days, 3.8 (1.1–12.8); Amnisure (+) fFN (−): 5.3 days, 5.0 (1.4–18.0); Amnisure (−) fFN (+): 25.7 days, 3.4 (1.3–8.5); Amnisure (−) fFN (−): 53.7 days, 1(reference)]
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cousins LM, Smok DP, Lovett SM, Poeltler DM. AmniSure placental alpha microglobulin-1 rapid immunoassay versus standard diagnostic methods for detection of rupture of membranes. Am J Perinatol. 2005;22:317–20. - PubMed
    1. Lee SE, Park JS, Norwitz ER, Kim KW, Park HS, Jun JK. Measurement of placental alpha-microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes. Obstet Gynecol. 2007;109:634–40. - PubMed
    1. Pollet-Villard M, Cartier R, Gaucherand P, Doret M. Detection of placental alpha microglobulin-1 versus insulin-like growth factor-binding protein-1 in amniotic fluid at term: a comparative study. Am J Perinatol. 2011;28:489–94. - PubMed
    1. Caughey AB, Robinson JN, Norwitz ER. Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol. 2008;1:11–22. - PMC - PubMed
    1. Tagore S, Kwek K. Comparative analysis of insulin-like growth factor binding protein-1 (IGFBP-1), placental alpha-microglobulin-1 (PAMG-1) and nitrazine test to diagnose premature rupture of membranes in pregnancy. J Perinat Med. 2010;38:609–12. - PubMed

Publication types

MeSH terms

Substances